Keywords
Covid-19
Hospital Pharmacy
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: Analyze, in a comparative way, the record of pharmaceutical care practice in the patient's medical record, before and during the Covid-19 pandemic in Brazilian hospitals. Methods: Exploratory, qualitative and quantitative study (survey), carried out electronically, from May to October 2022, with a questionnaire validated by a committee of experts. It was analyzed quantitatively (Friedman's ANOVA) and qualitatively (dendrogram and word cloud). Results: 14 responses were obtained. The study showed that before the pandemic, 283 (90.1%) of pharmacists recorded their activities in the medical record. There was an increase in the recording of clinical activities in the electronic medical record during the Covid-19 pandemic (p<0.001), increasing from 66.9% to 78.7%. These results were significant in clinical and pediatric Intensive Care Units and in transplantation. The Descending Hierarchical Analysis generated 4 classes: Pharmaceutical Record; Coping with Covid-19; Pharmaceutical Services and Evidence-Based Information. Conclusion: There was an increase in the recording of pharmaceutical practice in the patient's medical record during the Covid-19 pandemic, and the implementation of pharmaceutical services, however, the records have not yet reached the ideal value. The development of new studies is envisaged that present strategies to encourage this practice.
References
ALEXANDRE NMC e COLUCI MZO. Content validity in the processes and adaptation of measuring
instruments. Ciência & Saúde Coletiva. 2011;16(7): 3061-8.
AMARILES P, et al. Pharmacist’s role and pharmaceutical care during the COVID-19 pandemic. In: Coronavirus Disease-Covid-19. Cham: Springer International Publishing, 2021; 605-622.
BOMBARDA TB e JOAQUIM RHVT. Registro em prontuário hospitalar: historicidade e tensionamentos atuais. Cadernos Saúde Coletiva, 2022; 30: 265-273.
BRASIL. Ministério da Saúde. Portaria nº 1.820, de 13 de Agosto de 2009. Disponível em: http://conselho.saude.gov.br/ultimas_noticias/2009/01_set_carta.pdf. Acessado em: 10 de novembro de 2023.
BRASIL. Conselho Federal de Farmácia (CFF). Censo 2020. Disponível em: https://www.cff.org.br/pagina.php?id=801%26menu=801%26titulo=Dados%2. Acessado em: 05 de janeiro de 2022.
BRASIL. Conselho Federal de Farmácia (CFF). Resolução Nº 555 de 30 de novembro de 2011. Disponível em: https://www.cff.org.br/userfiles/file/resolucoes/555.pdf. Acessado em: 06 de dezembro de 2023.
BRASIL. TIC Saúde 2022. Pesquisa sobre o Uso das Tecnologias de Informação e Comunicação nos Estabelecimentos de Saúde Brasileiros, 2023. Disponível em: https://cetic.br/media/docs/publicacoes/2/20230803103100/tic_saude_2022_livroeletronico.pdf.Acessado em: 18 de outubro de 2023.
CAMARGO BV e JUSTO AM. Tutorial para uso do software de análise textual IRAMUTEQ. Florianópolis: Universidade Federal de Santa Catarina. 2013: 1-18.
COLIN SL e NUTTI C. Pharmaceutical intervention: Description of the role of the clinical pharmacist in intensive care units. Rev Bras Farm Hosp Serv Saude, 2022;13(2):0766.
EYSENBACH, Gunther et al. How to fight an infodemic: the four pillars of infodemic management. Journal of medical Internet research, 2020; 22(6): e21820.
FIP. Pandemic Preparedness, Response and Recovery, 2023. Disponível em: https://www.fip.org/file/5607. Acessado em: 16 de outubro de 2023.
FREITAS H, et al. O método de pesquisa Survey. Revista de Administração. 2000; 35(3): 105-112.
LIU S, et al. Providing pharmacy services during the coronavirus pandemic. International journal of clinical pharmacy. 2020; 42(2), 299-304.
MAIA DB, et al. Atuação interdisciplinar na Atenção Básica de Saúde: a inserção da Residência Multiprofissional. Saúde & Transformação Social, 2013; 4(1) :103-110.
NÉRI EDR, et al. Do Brazilian hospital pharmacists record, document, archive and disseminate their clinical practice?. Brazilian Journal of Pharmaceutical Sciences, 2019; 55: e17618.
PAUDYAL V, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: experiences of pharmacists from 16 European countries. Research in Social and Administrative Pharmacy, 2021; 17(8): 1507-1517.
RUBIO DM, et al. Objectifying content validity: conducting a contente validity study in social work research, 2003; 27(2): 94-105.
SBRAFH. Padrões Mínimos para Farmácia Hospitalar e Serviços de Saúde, 2017. Disponível em: https://www.sbrafh.org.br/site/public/docs/padroes.pdf. Acessado em: 05 de janeiro de 2022.
SERPA DL, et al. Cuidados farmacêuticos em uma Unidade Básica de Saúde do Distrito Federal: efetividade das intervenções farmacêuticas. Comunicação em Ciências da Saúde, 2019; 29(01): 30-35.
STORPIRTIS, Silvia, et al. A origem da Farmácia Clínica no Brasil, a Sociedade Brasileira de Farmácia Clínica e a harmonização de Conceitos e nomenclatura. Infarma-Ciências Farmacêuticas, 2023; 26: 351-363.
TOLEDO PPDS, et al. Prontuário Eletrônico: uma revisão sistemática de implementação sob as diretrizes da Política Nacional de Humanização. Ciência & saúde coletiva, 2021; 26: 2131-2140.
VELOSO VL, et al. Atividades farmacêuticas em um projeto social aplicadas em unidades de saúde básica: um relato de experiência. Revista de Casos e Consultoria, 2021; 12 (1): e244291.
VISACRI MB, et al. Role of pharmacist during the COVID-19 pandemic: a scoping review. Research In Social And Administrative Pharmacy, 2021; 17 (1): 1799-1806.
WATSON KE, et al. The evolution of pharmacists’ roles in disasters, from logistics to assessing and prescribing. Canadian Pharmacists Journal/Revue des Pharmaciens du Canada, 2020; 153 (3): 129-131.
WHO. Director-General’s opening remarks at the media briefing on COVID-19 – 11. 2020. Disponível em: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-mediabriefing- on-covid-19—11-march-2020. Acessado em: 20 de março de 2023.